» Articles » PMID: 16261317

Reduction of Abstinence-induced Withdrawal and Craving Using High-dose Nicotine Replacement Therapy

Overview
Specialty Pharmacology
Date 2005 Nov 2
PMID 16261317
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Decreasing withdrawal and craving during smoking cessation is a major aim of cessation medications. Prior studies have shown that Nicotine Replacement Therapy (NRT) decreases withdrawal symptom severity but have relied on retrospective reports and lacked robust measures of baseline symptoms or symptoms during unmedicated abstinence.

Objectives And Methods: We tested the effect of high-dose (35 mg) nicotine patch on withdrawal and craving during abstinence using real-time assessment with electronic diaries during ad libitum smoking, a brief period of experimentally directed trial abstinence, and the first 3 days of cessation. Subjects were 324 smokers randomized to high-dose nicotine patches or placebo.

Results: Treatment with active patches reduced withdrawal and craving during cessation and completely eliminated deprivation-related changes in affect or concentration.

Conclusion: High-dose NRT reduces withdrawal symptoms and craving and can eliminate some symptoms entirely.

Citing Articles

Associations between nicotine product use and craving among stable daily and non-daily users.

Reed B, Doran N, Courtney K Addict Behav. 2023; 146:107803.

PMID: 37423069 PMC: 10827279. DOI: 10.1016/j.addbeh.2023.107803.


Behavioural support and nicotine replacement therapy for smokeless tobacco cessation: protocol for a pilot randomised-controlled multi-country trial.

Siddiqui F, Bauld L, Croucher R, Jackson C, Kellar I, Kanaan M Pilot Feasibility Stud. 2022; 8(1):189.

PMID: 35996179 PMC: 9396808. DOI: 10.1186/s40814-022-01146-5.


Electronic Versus Traditional Data Collection: A Multicenter Randomized Controlled Perioperative Pain Trial.

Khan J, Jibb L, Busse J, Gilron I, Choi S, Paul J Can J Pain. 2022; 3(2):16-25.

PMID: 35005415 PMC: 8730625. DOI: 10.1080/24740527.2019.1587584.


Possible New Symptoms of Tobacco Withdrawal III: Reduced Positive Affect-A Review and Meta-analysis.

Klemperer E, Hughes J, Peasley-Miklus C, Callas P, Cook J, Streck J Nicotine Tob Res. 2020; 23(2):259-266.

PMID: 32188995 PMC: 7822099. DOI: 10.1093/ntr/ntaa044.


Lack of effect of transcranial direct current stimulation (tDCS) on short-term smoking cessation: Results of a randomized, sham-controlled clinical trial.

Falcone M, Bernardo L, Wileyto E, Allenby C, Burke A, Hamilton R Drug Alcohol Depend. 2018; 194:244-251.

PMID: 30497056 PMC: 6312458. DOI: 10.1016/j.drugalcdep.2018.10.016.


References
1.
Cosby R, Howard M, Kaczorowski J, Willan A, Sellors J . Randomizing patients by family practice: sample size estimation, intracluster correlation and data analysis. Fam Pract. 2003; 20(1):77-82. DOI: 10.1093/fampra/20.1.77. View

2.
Sayette M, Wertz J, Martin C, Cohn J, Perrott M, Hobel J . Effects of smoking opportunity on cue-elicited urge: a facial coding analysis. Exp Clin Psychopharmacol. 2003; 11(3):218-227. PMC: 2632972. DOI: 10.1037/1064-1297.11.3.218. View

3.
. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group. JAMA. 1991; 266(22):3133-8. View

4.
Killen J, Fortmann S . Craving is associated with smoking relapse: findings from three prospective studies. Exp Clin Psychopharmacol. 1997; 5(2):137-42. DOI: 10.1037//1064-1297.5.2.137. View

5.
Shiffman S, Scharf D, Shadel W, Gwaltney C, Dang Q, Paton S . Analyzing milestones in smoking cessation: illustration in a nicotine patch trial in adult smokers. J Consult Clin Psychol. 2006; 74(2):276-85. DOI: 10.1037/0022-006X.74.2.276. View